Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J.

JAMA. 2009 Jul 22;302(4):412-23. doi: 10.1001/jama.2009.1063. Review.

2.

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A.

JAMA. 2005 Oct 12;294(14):1799-809. Erratum in: JAMA. 2005 Dec 14;294(22):2848.

PMID:
16219884
3.

Major lipids, apolipoproteins, and risk of vascular disease.

Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J.

JAMA. 2009 Nov 11;302(18):1993-2000. doi: 10.1001/jama.2009.1619.

4.

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Lp-PLA(2) Studies Collaboration, Thompson A, Gao P, Orfei L, Watson S, Di Angelantonio E, Kaptoge S, Ballantyne C, Cannon CP, Criqui M, Cushman M, Hofman A, Packard C, Thompson SG, Collins R, Danesh J.

Lancet. 2010 May 1;375(9725):1536-44. doi: 10.1016/S0140-6736(10)60319-4.

5.

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J.

Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7. Epub 2009 Dec 22.

6.

Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.

Bennet A, Di Angelantonio E, Erqou S, Eiriksdottir G, Sigurdsson G, Woodward M, Rumley A, Lowe GD, Danesh J, Gudnason V.

Arch Intern Med. 2008 Mar 24;168(6):598-608. doi: 10.1001/archinte.168.6.598. Erratum in: Arch Intern Med. 2008 May 26;168(10):1089. Arch Intern Med. 2008 May 26;168(10):1096.

PMID:
18362252
7.

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.

Danesh J, Collins R, Peto R.

Circulation. 2000 Sep 5;102(10):1082-5.

8.

Lp(a) lipoprotein, vascular disease, and mortality in the elderly.

Ariyo AA, Thach C, Tracy R; Cardiovascular Health Study Investigators.

N Engl J Med. 2003 Nov 27;349(22):2108-15.

9.
10.

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.

JAMA. 2000 Apr 12;283(14):1845-52.

PMID:
10770146
11.

Subclinical hypothyroidism and the risk of coronary heart disease and mortality.

Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J; Thyroid Studies Collaboration.

JAMA. 2010 Sep 22;304(12):1365-74. doi: 10.1001/jama.2010.1361.

12.

Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study.

Gurdasani D, Sjouke B, Tsimikas S, Hovingh GK, Luben RN, Wainwright NW, Pomilla C, Wareham NJ, Khaw KT, Boekholdt SM, Sandhu MS.

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3058-65. doi: 10.1161/ATVBAHA.112.255521. Epub 2012 Oct 11.

13.

Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population.

D'Angelo A, Ruotolo G, Garancini P, Sampietro F, Mazzola G, Calori G.

Haematologica. 2006 Dec;91(12):1613-20.

14.

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.

Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V.

PLoS Med. 2008 Apr 8;5(4):e78. doi: 10.1371/journal.pmed.0050078. Review.

15.

Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.

Nestel PJ, Barnes EH, Tonkin AM, Simes J, Fournier M, White HD, Colquhoun DM, Blankenberg S, Sullivan DR.

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2902-8. doi: 10.1161/ATVBAHA.113.302479. Epub 2013 Oct 3.

16.
17.

Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).

Cantin B, Després JP, Lamarche B, Moorjani S, Lupien PJ, Bogaty P, Bergeron J, Dagenais GR.

Am J Cardiol. 2002 Mar 15;89(6):662-6.

PMID:
11897206
18.

A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.

Shai I, Schulze MB, Manson JE, Stampfer MJ, Rifai N, Hu FB.

Diabetologia. 2005 Aug;48(8):1469-76. Epub 2005 Jun 22. Erratum in: Diabetologia. 2005 Dec;48(12):2691-2.

PMID:
15971061
19.

Pediatric stroke among Hong Kong Chinese subjects.

Chung B, Wong V.

Pediatrics. 2004 Aug;114(2):e206-12.

PMID:
15286258
20.

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, Abolafia JM, Lippel K, Levy RI.

JAMA. 1994 Apr 6;271(13):999-1003.

PMID:
8139085

Supplemental Content

Support Center